- Home
- NUV vs BHC Comparison
NUV vs BHC Comparison
Compare NUV & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUV
- BHC
- Stock Information
- Founded
- NUV 1987
- BHC N/A
- Country
- NUV United States
- BHC Canada
- Employees
- NUV N/A
- BHC N/A
- Industry
- NUV Trusts Except Educational Religious and Charitable
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- NUV Finance
- BHC Health Care
- Exchange
- NUV Nasdaq
- BHC Nasdaq
- Market Cap
- NUV 1.8B
- BHC 1.7B
- IPO Year
- NUV N/A
- BHC N/A
- Fundamental
- Price
- NUV $8.55
- BHC $4.53
- Analyst Decision
- NUV
- BHC Hold
- Analyst Count
- NUV 0
- BHC 5
- Target Price
- NUV N/A
- BHC $7.20
- AVG Volume (30 Days)
- NUV 464.9K
- BHC 1.5M
- Earning Date
- NUV 01-01-0001
- BHC 04-30-2025
- Dividend Yield
- NUV 3.96%
- BHC N/A
- EPS Growth
- NUV N/A
- BHC N/A
- EPS
- NUV N/A
- BHC N/A
- Revenue
- NUV N/A
- BHC $9,731,000,000.00
- Revenue This Year
- NUV N/A
- BHC $3.71
- Revenue Next Year
- NUV N/A
- BHC $5.03
- P/E Ratio
- NUV N/A
- BHC N/A
- Revenue Growth
- NUV N/A
- BHC 8.53
- 52 Week Low
- NUV $7.86
- BHC $3.96
- 52 Week High
- NUV $9.08
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- NUV 42.16
- BHC 39.91
- Support Level
- NUV $8.48
- BHC $4.50
- Resistance Level
- NUV $8.57
- BHC $4.61
- Average True Range (ATR)
- NUV 0.07
- BHC 0.13
- MACD
- NUV -0.01
- BHC 0.03
- Stochastic Oscillator
- NUV 22.22
- BHC 21.30
About NUV Nuveen Municipal Value Fund Inc.
Nuveen Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.